SCHEMBL10136721

SCHEMBL10136721

COC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccccc12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 6/20 0.80
PIM2 Q9P1W9 6/20 0.80
CSNK2A2 P19784 1/20 0.53
CSNK2B P67870 1/20 0.53
CSNK2A1 P68400 1/20 0.53
ALOX5 P09917 2/20 0.50
MAPT P10636 4/20 0.48
PDE5A O76074 4/20 0.47
ABCG2 Q9UNQ0 3/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDR P35968 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2687706 0.89 PIM1 (1.00) PIM1PIM2CSNK2A2CSNK2BCSNK2A1
SCHEMBL12501123 0.81 MAPT (0.67) PIM1PIM2ALOX5MAPTMEN1
SCHEMBL25286410 0.80 CSNK2A1 (0.64) PIM1PIM2CSNK2A2CSNK2BCSNK2A1
SCHEMBL10136809 0.78 PIM1 (0.80) PIM1PIM2CSNK2A2CSNK2BCSNK2A1
SCHEMBL10134645 0.78 PIM1 (0.79) PIM1PIM2CSNK2A2CSNK2BCSNK2A1
SCHEMBL10168958 0.77 PIM1 (0.80) PIM1PIM2CSNK2A2CSNK2BCSNK2A1
SCHEMBL7271426 0.77 MEN1 (0.58) PIM1PIM2MAPTMEN1LMNA
SCHEMBL2688882 0.76 PIM1 (1.00) PIM1PIM2CSNK2A2CSNK2BCSNK2A1
SCHEMBL10136729 0.76 PIM1 (0.92) PIM1PIM2CSNK2A2CSNK2BCSNK2A1
SCHEMBL13688132 0.76 PIM1 (0.78) PIM1PIM2CSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-20090239859-A1 PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2009-09-24 US disclosed
US-20090239859-A1 PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239859-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 PIM1 1/4885PIM2 2/4885CSNK2A2 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.